Femtobiomed Inc. (XKON:327610)

Kronos Bio Balance Sheet

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	FY 2018	FY 2017
Period Ending	Dec 31, 2018	Dec 31, 2017
Cash & Equivalents	319.5	1,710
Cash & Short-Term Investments	319.5	1,710
Cash Growth	-81.31%	-
Accounts Receivable	22.97	72.35
Other Receivables	43.21	56.42
Receivables	66.18	128.77
Inventory	153.36	70.31
Prepaid Expenses	0.11	0.31
Other Current Assets	208.77	190.32
Total Current Assets	747.93	2,100
Property, Plant & Equipment	172.96	158.63
Other Intangible Assets	114.85	42.22
Other Long-Term Assets	135.28	130.37
Total Assets	1,171	2,431
Accrued Expenses	41.61	35.56
Current Portion of Long-Term Debt	-	61.05
Other Current Liabilities	19.46	25.62
Total Current Liabilities	61.07	122.23
Other Long-Term Liabilities	81.92	70.39
Total Liabilities	142.99	192.62
Common Stock	690.54	690.54
Additional Paid-In Capital	4,353	4,353
Retained Earnings	-4,136	-2,926
Total Common Equity	907.27	2,117
Shareholders' Equity	1,028	2,238
Total Liabilities & Equity	1,171	2,431
Total Debt	-	61.05
Net Cash (Debt)	319.5	1,649
Net Cash Growth	-80.62%	-
Net Cash Per Share	231.29	1194.21
Filing Date Shares Outstanding	1.38	1.38
Total Common Shares Outstanding	1.38	1.38
Working Capital	686.85	1,977
Book Value Per Share	656.78	1533.63
Tangible Book Value	792.42	2,075
Tangible Book Value Per Share	573.64	1503.05
Machinery	735.93	618.5

Source: S&P Global Market Intelligence. Standard template. Financial Sources.